The DHS Program User Forum
Discussions regarding The DHS Program data and results
Home » DHS-7 Questionnaire Review - Archived » Maternal and Child Health » Measuring ORS and zinc treatment coverage for diarrhea in children under five
Measuring ORS and zinc treatment coverage for diarrhea in children under five [message #1917] Tue, 08 April 2014 21:54
flam0119 is currently offline  flam0119
Messages: 6
Registered: April 2014
Dear DHS Program,

Thank you for the opportunity to suggest revisions to the DHS-7 Questionnaires. On behalf of the Diarrhea & Pneumonia Working Group's M&E Subgroup (see below for more information), we would like to suggest the following changes to improve the measurement of ORS and zinc coverage for the treatment of diarrhea:
• Revise Q.522 to include a prompt for zinc tablets or syrup
• Include in the tabulation plan measurements for coverage of ORS and zinc, coverage of ORS without zinc, and coverage of zinc without ORS in children under five with diarrhea

Please find attached the completed guideline form with additional information supporting these changes. If you have any questions, please do not hesitate to contact me. We again thank the DHS Program for taking our recommendation into consideration.

Warm regards,
Felix Lam
Monitoring and Evaluation Subgroup Lead, Diarrhea & Pneumonia Working Group
Monitoring and Evaluation Manager, Clinton Health Access Initiative (CHAI)

------------------------------------------------------------ ------------------------------
About the Diarrhea & Pneumonia Working Group
Formed in late 2011, the Diarrhea & Pneumonia Working Group aims to reduce mortality and morbidity from child diarrhea and pneumonia by accelerating treatment scale-up in 10 high-burden countries which account for over 60% of the global burden--Bangladesh, Democratic Republic of Congo, Kenya, India, Niger, Nigeria, Pakistan, Tanzania, and Uganda. The Working Group, co-chaired by the Clinton Health Access Initiative (CHAI) and UNICEF, consists of members from over 40 organizations working in child health including implementing partners, donors, and the private sector. Specifically, the Working Group provides technical assistance, resource mobilization, and monitoring and evaluation support to organizations and governments working to implement national scale-up plans for essential medicines and/or related RMNCH strategies (UN Commission on Life-Saving Commodities, GAPPD, A Promise Renewed, etc). For more information, please visit: ng-group/
Previous Topic: Tobacco/Smoking (Woman's Questionnaire 1004-1007)
Next Topic: Measuring ARI cases in children under age five
Goto Forum:

Current Time: Wed Jul 6 16:04:52 Coordinated Universal Time 2022